Multi-cancer early detection (MCED) tests represent a transformative breakthrough in cancer diagnostics, using blood samples to identify biomarkers like circulating…
Browsing: Clinical Updates
Dr. David Johnson shared key highlights from the 2024 American College of Gastroenterology (ACG) Annual Scientific Meeting, including promising research…
The American Gastroenterological Association (AGA) recently reviewed endoscopic scoring systems used to evaluate the severity of inflammation and mucosal healing…
In managing Crohn’s disease (CD), diet plays a significant role in symptom management and potentially impacts disease progression. Dr. Berkeley…
Colorectal cancer (CRC) remains a leading cause of cancer-related deaths, with several screening recommendations to enhance early detection. Despite differing…
The FDA has updated the labels for all glucagon-like peptide 1 receptor agonists (GLP-1 RAs), such as semaglutide (Ozempic, Wegovy),…
A recent study from the University of Pennsylvania indicates that GLP-1 receptor agonists, commonly used for weight loss and diabetes…
Gastroesophageal reflux disease (GERD) affects an estimated 1.03 billion people worldwide, with prevalence ranging significantly by region. Defined as a…
In 2030, the transformative potential of weight-loss drugs, particularly GLP-1 agonists like semaglutide (Ozempic/Wegovy), could yield global health and economic…
New tools in gastrointestinal bleeding (GIB) management, including hemostatic powders, capsule endoscopy, endoscopic clips, and over-the-scope devices, offer targeted approaches…